These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17328978)

  • 1. Bradycardia can induce increased serum natriuretic peptide-level.
    Kováts T; Wettstein A; Nagy E; Tomcsányi J
    Int J Cardiol; 2008 Jan; 123(2):e43-4. PubMed ID: 17328978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradycardia and B-type natriuretic peptide.
    Kováts T; Tomcsányi J
    Int J Cardiol; 2009 Jun; 135(2):238-9. PubMed ID: 18602177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):43-8. PubMed ID: 18243858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
    Yang CL; Qiu YR; Zhou F; Feng PF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.
    Frankenstein L; Nelles M; Slavutsky M; Schellberg D; Doesch A; Katus H; Remppis A; Zugck C
    J Heart Lung Transplant; 2007 Oct; 26(10):1033-9. PubMed ID: 17919624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM; Connolly DJ; Elliott J; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
    Bettencourt P; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
    Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
    Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients.
    Johns MC; Stephenson C
    Am J Cardiol; 2008 Feb; 101(3A):76-81. PubMed ID: 18243864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal pro-B-type natriuretic peptide testing in renal disease.
    DeFilippi C; van Kimmenade RR; Pinto YM
    Am J Cardiol; 2008 Feb; 101(3A):82-8. PubMed ID: 18243865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide (BNP) or N-terminal-proBNP for the diagnosis of heart failure: which peptide is the better choice?
    Kragelund C; Omland T
    Scand J Clin Lab Invest; 2005; 65(8):629-32. PubMed ID: 16319037
    [No Abstract]   [Full Text] [Related]  

  • 18. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S; Latini R
    Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.